Boiron SA

BOI

Company Profile

  • Business description

    Boiron SA is a drug manufacturer that focuses on homeopathic products. The company's revenue is roughly split between its nonproprietary homeopathic medicines and products in its over-the-counter specialties category. Boiron's nonproprietary medicines are generic products that do not refer to any therapeutic indication, while the specialties category includes first-resort products provided in tablet form, are bottled to use as drops, syrups, or ointments. Geographical segments are France, Europe, North America, and other countries. It generates a majority of revenue from France. The company’s products include Oscillococcinum, Stodal and Stodaline, Arnigel, Camilia, Sedatif PC, Coryzalia, Homeoptic, and Homeovox.

  • Contact

    2, Avenue de l’Ouest Lyonnais No. 039
    Messimy69510
    FRA

    T: +33 478456100

    E: [email protected]

    http://www.boiron.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    2,634

Stocks News & Analysis

stocks

ASX tech share tracking below guidance

Moat Rating downgraded for overvalued shares.
stocks

After plunge ASX blue chip undervalued

This company earns a moat from our analysts.
stocks

Older cohorts the budget losers, not necessarily the ASX listed insurers

Proposed legislation removes health insurance rebates.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,829.5017.300.20%
CAC 407,981.765.73-0.07%
DAX 4024,400.6592.730.38%
Dow JONES (US)49,363.88322.24-0.65%
FTSE 10010,330.556.800.07%
HKSE25,797.85122.670.48%
NASDAQ25,870.71220.02-0.84%
Nikkei 22560,550.59265.36-0.44%
NZX 50 Index12,825.99148.33-1.14%
S&P 5007,353.6149.44-0.67%
S&P/ASX 2008,604.7023.100.27%
SSE Composite Index4,169.5438.010.92%

Market Movers